# Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients

> **NCT03733652** · NA · UNKNOWN · sponsor: **Third Affiliated Hospital, Sun Yat-Sen University** · enrollment: 100 (estimated)

## Conditions studied

- Chronic Hepatitis b
- Efficacy, Self

## Interventions

- **DRUG:** Interferon Alfa 2a

## Key facts

- **NCT ID:** NCT03733652
- **Lead sponsor:** Third Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-15
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03733652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03733652, "Optimal Treatment for Poor Efficacy of Entecavir in Chronic Hepatitis B Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03733652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*